Migraine: Novel Treatments

CE / CME

Getting Ahead on Migraine Management: The Place for Novel Options

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: January 23, 2023

Expiration: January 22, 2024

Jessica Ailani
Jessica Ailani, MD

Pretest

Progress
1 2
Course Completed
1.

Which of the following is a red flag that suggests a patient may have a serious form of secondary headache requiring immediate investigation?

2.

Preventive treatment for episodic migraine headaches should be offered when your patient:

3.

Monoclonal antibody calcitonin gene-related peptide (CGRP) inhibitors are FDA approved for:

4.

How often do you currently use the ID MigraineTM simplified diagnostic criteria for migraine?

5.

How often do you currently consider starting preventive therapy for patients with <15 migraine days/month?

6.

How often do you currently consider an anti-CGRP agent for patients with episodic or chronic migraine?